Your session is about to expire
← Back to Search
[11C]-(R)-Rolipram Imaging for Depression
Study Summary
This trial is testing whether ketamine affects brain cells with low levels of cAMP, which may cause depression.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You must have a score of at least 18 on the MADRS scale or 15 on the HAM-D scale within two weeks before joining the study.The investigator believes that you are currently at a high risk of wanting to harm yourself or others.You currently have symptoms of mental illness that affect your thinking and perception, such as hallucinations or delusions.You have a history of behaving aggressively towards others.
- Group 1: Subjects with major depression disorder (MDD)
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who has been invited to partake in the investigation?
"This clinical trial has a limited sample size of 35 participants and requires that those enrolled have been diagnosed with depression, aged between 18 to 70 years."
Could one still partake in this investigation?
"Unfortunately, the clinical trial mentioned is not accepting new participants at this time; it was posted on December 7th 2022 and last edited on December 1st 2022. Nevertheless, 1134 other studies are welcoming candidates for enrollment."
Does the trial encompass seniors of seventy or more years in age?
"This study is open to individuals between the ages of 18 and 70. Furthermore, there are 177 trials catered towards minors and 848 for seniors over 65 years old."
Has this particular medical treatment been certified by the FDA?
"Our team at Power gave this treatment a score of 1, as it is in the early stages of clinical testing with limited data on efficacy and safety."
Share this study with friends
Copy Link
Messenger